TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | -2 | 1 | -3 | 6 | 2 | -33 | -5 |
P | %wins | 0 | 100 | 0 | 100 | 100 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/16/24 18:06 | 1/11/24 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ferrari Mauro | CA | D | S | -120 | 38.06 | 0 | -3 | -5 | 61 | D | |||||||||||||||
12/29/21 20:41 | 12/28/21 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ferrari Mauro | CA | D | S | -227 | 66.82 | 0 | -3 | -9 | 37 | D | |||||||||||||||
10/13/20 18:01 | 10/9/20 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ferrari Mauro | CA | D | S | -480 | 48.00 | 0 | -10 | -24 | 31 | D | |||||||||||||||
6/28/19 19:19 | 6/26/19 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ferrari Mauro | CA | D | S | -490 | 27.61 | 0 | -18 | -90 | 2 | D | |||||||||||||||
1/14/15 18:10 | 10/9/13 | ARWR | Arrowhead Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | Ferrari Mauro | CA | D | P.m | 15 | 6.44 | 26 | 2 | 118 | 4 | D | 191 | -49 | -48 | 5 | 17 | -4 | -18 | -21 | -2 | 1 | -3 | 6 | 2 | -33 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |